Discover 1,758 paid clinical trials in Ann Arbor, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,758
Phase II Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation
for
Allogeneic Stem Cell Transplant
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT06784336
Phase 2, Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
for
Prostate Cancer (Adenocarcinoma)
Location: Ann Arbor MI, Brighton MI, Novi MI, West Bloomfield MI,
Sponsor: Canadian Cancer Trials Group
Sex: Male
Age: 18+
Code: NCT06592924
Phase 3, Recruiting
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
for
Prostate Cancer
Location: Ann Arbor MI, Madison WI, Durham NC, San Francisco CA
Sponsor: Duke University
Sex: Male
Age: 18+
Code: NCT07050433
Recruiting
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
for
Gastric Cancer, Gastroesophageal Junction Cancer
Location: Ann Arbor MI, Skokie IL, Toronto, Hershey PA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06731478
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: Ann Arbor MI, Ypsilanti MI, Canton MI, Chelsea MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT05564377
Phase 2, Recruiting
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
for
Metastatic Salivary Gland Carcinoma,
Location: Ann Arbor MI, Columbus OH, Farrell PA, Erie PA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05408845
Phase 2, Recruiting
Metastatic Leiomyosarcoma Biomarker Protocol
for
Leiomyosarcoma
Location: Ann Arbor MI, Columbus OH, Nashville TN, Rochester MN,
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 0+
Code: NCT05653388
Recruiting
A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)
for
Oropharyngeal Cancer, Squamous Cell Carcinoma of the Oropharynx
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT05894083
Phase 2, Recruiting
Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms
for
T-Cell Neoplasm, Lymphoproliferative Disorders
Location: Ann Arbor MI, Columbus OH, Durham NC, Duarte CA
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT04858256
Phase 2, Recruiting
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
for
Metastatic Thyroid Cancer
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT03099356
Phase 2, Recruiting
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
for
Classic Follicular Lymphoma,
Location: Ann Arbor MI, Ypsilanti MI, Canton MI, Chelsea MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06337318
Phase 3, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Ann Arbor MI, Canton MI, Chelsea MI, Brighton MI,
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05946213
Phase 3, Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
for
Metastatic Renal Cell Carcinoma,
Location: Ann Arbor MI, Ypsilanti MI, Canton MI, Chelsea MI,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05327686
Phase 2, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Ann Arbor MI, Ypsilanti MI, Canton MI, Chelsea MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05987241
Phase 2, Phase 3, Recruiting
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
for
Pancreatic Acinar Cell Carcinoma,
Location: Ann Arbor MI, Ypsilanti MI, Canton MI, Chelsea MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04858334
Phase 2, Recruiting
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
for
Childhood Extracranial Germ Cell Tumor,
Location: Ann Arbor MI, Royal Oak MI, Detroit MI, Sylvania OH,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT03067181
Phase 3, Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
for
Metastatic Malignant Neoplasm in the Lung,
Location: Ann Arbor MI, Royal Oak MI, Detroit MI, Toledo OH,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT05235165
Phase 3, Recruiting
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: Ann Arbor MI, Detroit MI, Cleveland OH, Chicago IL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06385080
Phase 1, Phase 2, Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
for
Refractory Differentiated Thyroid Gland Carcinoma
Location: Ann Arbor MI, Ypsilanti MI, Canton MI, Chelsea MI,